AMPEL BioSolutions is a precision medicine company with a pipeline of gene expression tests for blood or tissue samples that provide decision support by determining immunological status, identifying molecular pathways and predicting drug options. AMPEL’s data science technology is scalable, translatable and provides an evidence-based disease management through machine learning of RNA & DNA analytics, covering 95% of all known genes. AMPEL provides patient-centric clinical care for lupus disease.